Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
Abstract Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy by harvesting infiltrated lymphocytes from tumors, culturing and amplifying them in vitro and then infusing back to treat patients. Its diverse TCR clonality, superior tumor-homing ability, and low off-target...
Main Authors: | Shuhang Wang, Jingwei Sun, Kun Chen, Peiwen Ma, Qi Lei, Shujun Xing, Zhongzheng Cao, Shujun Sun, Zicheng Yu, Yarong Liu, Ning Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-021-02006-4 |
Similar Items
-
Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully
by: Baisheng Lin, et al.
Published: (2020-12-01) -
ACT Up TIL Now: The Evolution of Tumor-Infiltrating Lymphocytes in Adoptive Cell Therapy for the Treatment of Solid Tumors
by: Thomas Morgan Hulen, et al.
Published: (2021-07-01) -
Assessment of the presence and anti-tumor potential of tumor-infiltrating lymphocytes in patients with acute myeloid leukemia
by: Wei L, et al.
Published: (2019-04-01) -
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer
by: Michael Poch, et al.
Published: (2018-09-01) -
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy
by: Elise Ballot, et al.
Published: (2020-08-01)